2005 First Year Grants Awarded - Ralph Wilson Medical Research Foundation

The Ralph Wilson Medical Research Foundation is proud to announce the following first year grant and second year grant renewal recipients for the 2005 cycle:

2005 FIRST YEAR GRANTS AWARDED
Cleveland Clinic: Riquiang Yan, Ph.D. Principal Investigator
The role of RTN3 in the formation of dystrophic neuritis

Mayo Clinic: Vanda A. Lennon, MD, Ph.D., Principal Investigator
Autoimmunity Targeting Water Channels

Miami Project: Daniel J. Liebl, Ph.D., Principal Investigator
Eph receptors are new and novel regulators of cell survival following spinal cord injury

Roswell Park Cancer Institute: Ashwani Rajput, MD, Principal Investigator
Potential Avenues for Extending EGRF Efficacy

University of Michigan: Kenneth Pienta, MD, Shuichi Takayama, Ph.D., Co-Investigators
Utilizing Microfluidics Technology for Characterizing prostata Cancer Stem Cells as a Therapeutic Target to Treat Prostate Cancer

Wayne State University: Maik Hutteman, Ph.D., Principal Investigator
Optimized infrared light therapy applied to neurodegenerative disease

2005 SECOND YEAR GRANTS AWARDED:
Cleveland Clinic: Richard A. Padgett, Ph.D., Principal Investigator
Transcription and Processing of Giant Tumor Suppressor Genes at Chromosomal Fragile Sites

Mayo Clinic: Andre Terzic, M.D. Ph.D., Principal Investigator
Recruiting a cardiogenic cell population for safe heart repair

Miami Project: Barbara Grimpe, Ph.D., Principal Investigator
Biochemistry of proteoglycans after spinal cord injury

Roswell Park Cancer Institute: Athena Lin, Ph.D., Principal Investigator
Oncogenic Ras-induced Growth Suppression of Human Breast Carcinomas

University of Michigan: Howard R. Petty, Ph.D., Principal Investigator
Signal Waves in Tumor Cell Killing: A Systems Biology Approach in Oncology

Wayne State University: Rafael Fridman, Ph.D., Principal Investigator
New nanotechnological tools to study the distribution and diffusion of cancer metastasis-associated proteases at the cell membrane.

The Ralph Wilson Medical Research Foundation was established in 1999 by Ralph C. Wilson, Jr., and is dedicated to supporting innovative, high risk/high impact biomedical research. The Foundation has contributed over $7,500,000 to the effort since its inception and provides grant funding exclusively to six partner institutions. It is designed to foster novel and innovative research in the areas of cardiovascular diseases, cancer, neurosciences and musculoskeletal disorders. Please see the foundation web site, www.rwmrf.org, for more information.

If you have any questions about this announcement, please contact Mary Owen at the Ralph Wilson Medical Research Foundation at 313-885-5263 or send us an e-mail: http://www.rwmrf.org/contact.html.